DAIC

FEBRUARY 9, 2024

Physicians in the Smidt Heart Institute at Cedars-Sinai have pioneered using a catheter-based approach to treat patients with tricuspid valve disease. The first 100 minimally invasive tricuspid procedures were done as part of the TRISCEND II clinical trial. Corday, MD, Chair in Interventional Cardiology. “It

Tricuspid 105

Tricuspid Open-Heart Surgery Interventional Cardiology Bicuspid/Mitral 105

DAIC

JUNE 21, 2024

milla1cf Fri, 06/21/2024 - 20:10 June 21, 2024 — UC San Francisco interventional cardiologists and interventional echocardiographers recently performed the health system’s first commercial transcatheter tricuspid valve replacement procedure using the Edwards EVOQUE system. by the Food and Drug Administration.

Tricuspid 105

Tricuspid Quality of Life Open-Heart Surgery Interventional Cardiology 105

DAIC

JUNE 11, 2024

Columbia University Irving Medical Center’s Division of Cardiology has announced its launch of the Mitral & Tricuspid Center. Tricuspid and mitral valves are debilitating conditions that can lead to arrhythmias, hypertension, and heart failure.

Tricuspid 111

Tricuspid Bicuspid/Mitral Heart Valves Innovation 111

ADN Center of Excellence

MARCH 18, 2024

In the dynamic realm of interventional cardiology, education is the cornerstone of excellence. ADN CoE recently hosted a groundbreaking Mitral & Tricuspid Valve Interventions Training, uniting cardiologists from around the globe for an immersive learning experience. Ismail Ates, Assoc.

Tricuspid 52

Tricuspid Bicuspid/Mitral Interventional Cardiology Education 52

DAIC

JUNE 11, 2024

Columbia University Irving Medical Center’s Division of Cardiology has announced its launch of the Mitral & Tricuspid Center. Tricuspid and mitral valves are debilitating conditions that can lead to arrhythmias, hypertension, and heart failure.

Tricuspid 52

Tricuspid Bicuspid/Mitral Heart Valves Innovation 52

DAIC

APRIL 16, 2024

Clinical Director of Interventional Cardiology at the Thoraxcentre, Erasmus Medical Centre in Rotterdam, The Netherlands, as part of the company’s ELITE Venous Clinical Study—a prospective, multi-center, single-arm clinical study evaluating the safety and efficacy of the vascular closure system. Nicolas Van Mieghem , M.D.

Technology 105

Technology Interventional Cardiology Tricuspid Bicuspid/Mitral 105

CardiacWire

NOVEMBER 3, 2024

This year’s TCT conference saw a deluge of TAVR studies examining everything from the efficacy of valve designs to TAVR’s impact on aortic and tricuspid regurgitation. performed TAVRs (-50% overall, -73% disabling), but no stroke benefits when performed outside the U.S.

TAVR 59

TAVR Embolism Aortic Interventional Cardiology 59